|
Delayed
Bombay S.E.
07:52:58 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,740.00 INR | -1.90% |
|
-3.15% | +47.83% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.22B | - | - | |||
| 46.7B | |||||
| 39.11B | |||||
| 11.66B | |||||
| 11.6B | |||||
| 9.19B |
Select your edition
All financial news and data tailored to specific country editions
